ArchiMed Mergers and Acquisitions Summary

Private Equity Profile

In the last 3 years, ArchiMed has acquired 3 companies.

ArchiMed’s most common sectors for investment are healthcare services (39%) and medical products (31%). The Firm’s most common investment types include buyout (lbo, mbo, mbi) (54%) and secondary buyout (24%). In total, ArchiMed has invested in 1 US state and 6 different countries. Its largest (disclosed) acquisition occurred in 2019 when it acquired Bomi Italia for $79M.

In the last 3 years, ArchiMed has exited 1 company. The Firm’s most common exit type is secondary buyout (100%).

Join Mergr to view ArchiMed’s full profile and discover more middle-market private equity firms just like it.

M&A Summary

  • M&A Total Activity14
    • M&A Buy Activity13
    • M&A Sell Activity1
  • Total Sectors Invested 5
  • Total Countries Invested 6
  • M&A Advisors 1

ArchiMed is a specialist French private equity firm focused on buyouts of and growth capital investments in European healthcare-oriented companies. The Firm looks to invest €5 to €30 million per transaction and specifically targets companies in the public health, care and wellness, biotech, and medical technology segments of the healthcare industry. ArchiMed was formed in 2014 and is headquartered in Lyon.


Investment Criteria

Sectors of Interest: Healthcare Services, Life Science, Medical Products

Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital, Recapitalization, Stake Purchase

Geographic Preferences: United Kingdom, Western Europe, Eastern Europe, Scandinavia

Transaction Criteria Min Max
Target Revenue 5 100
Target EBITDA - -
Investment Size 5 30
Enterprise Value - -
values in millions of EUR

M&A Summary

Buy vs Sell

Year ≤ '15 '16 '17 '18 '19 '20 T
Buy (1.6/yr) # 5 3 - 2 3 - 13
vol $14M $79M $92M
Sell (0.2/yr) # - - - - 1 - 1
  14

Most Recent M&A

Company Date Value Type
Direct Healthcare Services Ltd. 2019-12-09 - Secondary Buyout
Caerphilly, United Kingdom · www.directhealthcareservices.co.uk
Primo Group S.p.A. 2019-10-14 - Secondary Buyout
Torino, Italy · www.centridentisticiprimo.it
Eurolyser Diagnostica GmbH 2019-07-09 - Buyout (LBO, MBO, MBI)
Salzburg, Austria · www.eurolyser.com
Bomi Italia S.p.A. 2019-03-01 79M EUR Going Private
Vaprio d’Adda, Italy · www.bomigroup.com
Clean Cells 2018-11-22 - Secondary Buyout
Bouffere, France · www.clean-cells.com
Soest Medical Group 2018-04-09 - Buyout (LBO, MBO, MBI)
Oostergracht 2 , Netherlands · www.soestmedicalgroup.com
Polyplus-transfection SA 2016-09-20 - Buyout (LBO, MBO, MBI)
Illkirch, France · www.polyplus-transfection.com
Fytexia SAS 2016-09-20 - Buyout (LBO, MBO, MBI)
Vendres, France · www.fytexia.com
Micromed France SAS 2016-09-20 - Buyout (LBO, MBO, MBI)
Macon, France · www.micromed-france.eu
Deallus Consulting Ltd 2015-11-09 - Buyout (LBO, MBO, MBI)
London, United Kingdom · www.deallusconsulting.com
View All >>

Portfolio M&A

Company Acquired Add-On/Sale Date #
Micromed France SAS 2016-09-20 OSG BVBA (Onafhankelijke Software Groep) 2019-10-08 1
Macon, France · www.micromed-france.eu Rumst, Belgium · www.brainrt.com

M&A by Sector

Sector Current # Value All-time # Value
Healthcare Services 4 (33%) 92M (100%) 5 (38%) 92M (100%)
Medical Products 4 (33%) - 4 (31%) -
Life Science 2 (17%) - 2 (15%) -
Business Services 1 (8%) - 1 (8%) -
Food 1 (8%) - 1 (8%) -
Total 12 $92M 13 $92M

Acquisitions By Geo

State/Country Current # Value All-time # Value
France 4 (33%) - 4 (31%) -
United Kingdom 3 (25%) - 3 (23%) -
Italy 2 (17%) 79M (85%) 3 (23%) 79M (85%)
United States 1 (8%) 14M (15%) 1 (8%) 14M (15%)
  Georgia 1 (8%) 14M (15%) 1 (8%) 14M (15%)
Austria 1 (8%) - 1 (8%) -
Netherlands 1 (8%) - 1 (8%) -
Total 12 $92M 13 $92M

Acquisitions by Deal Type

Type Current # Value All-time # Value
Buyout (LBO, MBO, MBI) 7 (58%) 14M (15%) 7 (54%) 14M (15%)
Secondary Buyout 3 (25%) - 3 (23%) -
Growth Capital 1 (8%) - 2 (15%) -
Going Private 1 (8%) 79M (85%) 1 (8%) 79M (85%)
Total 12 $92M 13 $92M

Exits by Deal Type

Type Total # Value
Secondary Sale 1 (100%) -
Total 1 -

Top M&A Advisors

Legal Deals
Gianni Origoni Grippo & Partners
 1

Deal Values

buy # Total
< $100M 2 $92M
TOTAL $92M
Largest Bomi Italia S.p.A.
$79M (2019-03-01)

M&A Connections

Deals %
Acquired from
PE Firm(s)
100%
3 100%
Exited to
PE Firm(s)
100%
1 100%

Investor Summary

Size

Middle-Market

Established

2014

Specialist/Generalist

Specialist

Leadership

Vincent Guillaumot

Co-Founder & Managing Partner

Robin Filmer-Wilson

Managing Partner

Denis Ribon

Co-Founder & Managing Partner

Christoph Bohmer

Operating Partner

Loic Kubitza

Partner

Mergr

Product

Company

Legal